Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
prednisolone (Schering AG)
- Development stage
- Approved
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Administration
- Oral, Intravenous, Intramuscular, Topical, Rectal, Ophthalmic, Intraarticular
01
Overview
Prednisolone is a corticosteroid used to reduce inflammation and suppress the immune system. It is used to treat various conditions such as severe allergies, arthritis, asthma, blood disorders, and autoimmune diseases. Prednisolone works by mimicking the effects of cortisol, a hormone produced by the adrenal glands, to reduce inflammation and immune responses.
- Brand names
- Bubbli-PredCotonoloneFlo-PredMillipredMillipred DPOrapredOrapred ODTPediapredPreloneVeripred 20Veripred20Veripred-20
- Other names
- prednisolona
02
Targets
GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)
Beyond the preview
Go deeper on prednisolone (Schering AG).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on prednisolone (Schering AG).